Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Mark S. Litwin, M.D., M.P.H.
Mark S. Litwin, M.D., M.P.H.



General Information:



Professor, Department of Health Services, Department of Urology
Chair, Department of Urology
Director, Testicular Cancer Program, Institute of Urologic Oncology
Member, JCCC Patients and Survivors Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center


Public Health/Public Policy, UCLA Fielding School of Public Health, 1991 - 1993
Urology, Brigham and Women's Hospital, 1987 - 1991
Surgery, Brigham and Women's Hospital, 1985 - 1987
Medical Degree:
M.D., Emory University School of Medicine, 1985


Board Certification(s):
Urology, American Board of Urology, 1995

Contact Information:

(310) 794-7700 Urology and Genitourinary Oncology information and referral
(310) 794-2513 Prostate Research and Treatment Program information and referral

Practice Information:

Clinical Interest(s):
Bladder Cancer
Kidney Cancer
Nerve Sparing Prostatectomy
Penile Cancer
Prostate Cancer
Prostate Nodules
Testicular Cancer
Urinary Diversion

Scientific Interest(s):

Dr. Mark S. Litwin devotes his time to surgical care and research for patients with urologic cancers. His research activity focuses on quality of care and medical outcomes assessment, health-related quality of life, medical decision-making and prostate cancer in the underserved. He has published numerous quality-of-care and quality-of-life measures (including the UCLA Prostate Cancer Index) for use in men with prostate cancer. He has also published extensively on quality of care in patients with bladder and kidney cancer. His research has been continuously R-01 funded by the National Institutes of Health since 1997. He has also received grants from the American Cancer Society, Department of Defense, California Department of Public Health, and other organizations.

Litwin directs IMPACT (, a $73-million program for low-income, uninsured Californians with prostate cancer. He is also the principal investigator of Urologic Diseases in America (, a $14-million NIH project quantifying the burden of urologic diseases on the American public. His former fellows serve in academic positions throughout the world.

Selected Cancer-Related Publications:

Chamie K, Saigal CS, Lai J, Hanley JM, Setodji CM, Konety BR, Litwin MS; Urologic Diseases in America Project. Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer. 2011 Dec 1;117(23):5392-401. doi: 10.1002/cncr.26198. Epub 2011 Jul 11.

Chamie K, Saigal CS, Lai J, Hanley JM, Setodji CM, Konety BR, Litwin MS; Urologic Diseases in America Project. Quality of care in patients with bladder cancer: a case report? Cancer. 2012 Mar 1;118(5):1412-21. doi: 10.1002/cncr.26402. Epub 2011 Aug 5.

Bergman J, Saigal CS, Lorenz KA, Hanley J, Miller DC, Gore JL, Litwin MS; Urologic Diseases in America Project. Hospice use and high-intensity care in men dying of prostate cancer. Arch Intern Med. 2011 Feb 14;171(3):204-10. Epub 2010 Oct 11.

Daskivich TJ, Chamie K, Kwan L, Labo J, Palvolgyi R, Dash A, Greenfield S, Litwin MS. Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer. 2011 May 15;117(10):2058-66. doi: 10.1002/cncr.25751. Epub 2010 Nov 29.

Miller DC, Litwin MS, Bergman J, Stepanian S, Connor SE, Kwan L, Aronson WJ. Prostate cancer severity among low income, uninsured men. J Urol. 2009 Feb;181(2):579-83; discussion 583-4. Epub 2008 Dec 18.